0
Inquiry Basket

There is no product in the shopping cart, buy it!

GlycoErase™ SLC35A1 Knockout Human Prostate Cancer Cell 22RV1 (CAT#: GLJF-0525-JF334)

Datasheet
SizeQtyAdd To Basket
1 M cells/vial*2

Description The SLC35A1-deficient 22RV1 cell line allows investigation of nucleotide sugar transport disruption into the Golgi in prostate cancer, potentially affecting Golgi glycosylation, sialylation, and glycosylatioN-dependent processes.
Product Type KO Cell Lines
Species Human
Cell Morphology Epitheloid cells, adherent
Passage Ratio 1:3~1:10
Cell Line 22RV1
Primary Disease Prostate Adenocarcinoma
Lineage Prostate
Cell Viability >90%
Sterility Test The sterility test indicated an absence of microbial growth.
Identity Test STR identification
Mycoplasma Test Negative
Virus Test Negative for HIV, HBV and HCV.
Genetic Stability Testing We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation PCR, Sanger Sequencing
Culture Medium DMEM & FBS & RPMI
Application Functional assay
Size 1 M cells/vial*2
Product Format Frozen
Shipping Dry ice
Availability Status Made to order
Handling Notes Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.
Target SLC35A1
Full Name Solute carrier family 35 member A1
Alternative Name CMP-Sia-Tr, hCST, CMPST
Location 6q15
Gene ID 10559
Summary Transports nucleotide sugars, including CMP-sialic acid, into the Golgi apparatus for glycosylation; defects cause congenital disorder of glycosylation type 2F (CDG2F).
For Research Use Only.
Online Inquiry
Creative Biolabs-Glycoprotein Follow us on
Close
Thanksgiving
Thanksgiving